Isofol Medical: Patent portfolio strengthened
Research Note
2018-08-31
11:55
Isofol Medical announced this morning that a patent has been approved in the USA, strengthening the patent protection for arfolitixorin significantly. The patent covers the active pharmaceutical ingredient (API), the drug product and the finalised solution that is administered to patients.
AN
Arvid Necander
Disclosures and disclaimers